Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Clinical trial NCT01480050 · COMPLETED

Trial details

NCT number: NCT01480050
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2012-05-31
Primary completion: 2015-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.